CN110302308A - Pseudobulbus Cremastrae seu Pleiones extract is preparing the application in overriding resistance Acinetobacter bauamnnii drug - Google Patents
Pseudobulbus Cremastrae seu Pleiones extract is preparing the application in overriding resistance Acinetobacter bauamnnii drug Download PDFInfo
- Publication number
- CN110302308A CN110302308A CN201910493104.3A CN201910493104A CN110302308A CN 110302308 A CN110302308 A CN 110302308A CN 201910493104 A CN201910493104 A CN 201910493104A CN 110302308 A CN110302308 A CN 110302308A
- Authority
- CN
- China
- Prior art keywords
- acinetobacter bauamnnii
- drug
- extract
- edible tulip
- pseudobulbus cremastrae
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/898—Orchidaceae (Orchid family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation, decoction
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Biotechnology (AREA)
- Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Epidemiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Alternative & Traditional Medicine (AREA)
- Mycology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses Pseudobulbus Cremastrae seu Pleiones extracts to prepare the application in overriding resistance Acinetobacter bauamnnii drug.The present invention treats the nematode for having infected drug resistance Acinetobacter bauamnnii using the extract of edible tulip, show that the extract of edible tulip has good internal bactericidal effect to drug resistance Acinetobacter bauamnnii, this provides good early-stage study basis to research and develop novel overriding resistance Acinetobacter bauamnnii drug, brings dawn without the available predicament of medicine to solve clinically drug resistance Acinetobacter bauamnnii infection.Using extract the preventing and treating to drug resistance Acinetobacter bauamnnii of edible tulip, method is quick, cheap, and it is convenient to operate.
Description
Technical field
The present invention relates to field of biotechnology, more particularly, to Pseudobulbus Cremastrae seu Pleiones extract to prepare overriding resistance Bao Man motionless
Application in bacillus drug.
Background technique
Acinetobacter bauamnnii is one of the most common type non-fermented Gram-negative bacteria in acinetobacter, belongs to opportunistic
Bacterium is classified as the superbacteria for needing override to solve by the World Health Organization.The bacterium can be faced in hospital environment with long-term surviving
The distribution of bed department is mainly most with ICU, is secondly Respiratory Medicine.Gerontal patient, Abwehrkraft des Koepers be weak and the patient of critical illness,
And using various store periods and be used for a long time broad-spectrum antibiotic therapy patient be susceptible object.Acinetobacter bauamnnii tool
There is the ability for being quickly obtained and propagating drug resistance, drug resistance Acinetobacter bauamnnii shows worldwide fashion trend, it has also become China
One of most important pathogen of nosocomial infection.It is shown according to CHINET bacterial drug resistance monitoring network data in 2018, China 35
Teaching hospital, family Acinetobacter bauamnnii, which accounts for about, is clinically separated the 14.7% of gram-negative bacteria, is only second to escherichia coli and pneumonia gram
The primary bacterium of thunder.And in terms of to clinical common antibiotics drug resistance, Acinetobacter bauamnnii is to penicillins, cephalosporins, carbon mould
Alkenes, the beta-lactam class antibiotic/compound formulation of beta lactamase restrainer, fluoroquinolones, the resistant rate of aminoglycoside
Reach 45.7-80.4%, only there is lower resistant rate to tigecycline and polymyxins.But polymyxins has biggish kidney
Toxicity and constrain its clinical application, and tigecycline is expensive, and there are some defects for its distribution and metabolism, it would be highly desirable to which development is new
Type overriding resistance Acinetobacter bauamnnii drug.
Heat-clearing and detoxifying herb has accumulated experience abundant in terms of the treatment of infectious diseases.Early in Han dynasty treatise on Febrile Diseases
Just summarize many effective prescriptions, such as Xiexin Tang, gegen qinlian decoction, baitouweng decoction.Think now with many scholars
Treatise on Febrile Diseases as classical works it is practical be exactly an infectious diseases monograph, Qing Dynasty's " pestilence opinion ", " Wen Bing Tiao Bian " etc. write
The appearance of work, so that the Couple herbs of infectious diseases have obtained further enriching, it is anti-infective for further investigation traditional Chinese medicine
Treatment provides precious resources.Domestic and foreign scholars have done a lot of work to Chinese herbal antibacterial Effect study at present, test and face
Bed research all obtains certain achievement.However, these researchs are mostly antibacterial activity in vitro research, to high toxicity, pharmacokinetics
The compound of matter difference and In vitro-in vivo correlation difference lacks effective elimination method, therefore fails to obtain reliable result of study always.
Edible tulip, Chinese medicine name.For the drying pseudobulb of orchid Cremastra appendiculata, pleione bulbocodioides or Pleione yunnanensis.The former practises
Claiming " Mao Cigu, ", the latter two practise the also golden lamp of title " pleionebulbocodioides rolfe, " alias, aunt Zhu, wintergreen, nonsense grass etc..Summer, Qiu Erji are adopted
It digs.Edible tulip is sweet in flavor, micro-pungent, cool in nature.With clearing heat and detoxicating, carbuncle that disappears dissipating bind and other effects, it is usually used in carbuncle, swelling and furuncle, scrofula subcutaneous nodule,
Snakebite and bugbite, lame lump in the abdomen lump in the abdomen.It there are no the report of its antibacterial and antimicrobial agent effect at present.
Summary of the invention
The present invention is directed to overcome in the prior art not yet discovery insufficient, research for the effective Chinese medical extract of drug-fast bacteria
It was found that a kind of new overriding resistance Acinetobacter bauamnnii drug, i.e. Pseudobulbus Cremastrae seu Pleiones extract.
The first purpose of the invention is to provide edible tulips to prepare the application in overriding resistance Acinetobacter bauamnnii drug.
A second object of the present invention is to provide Pseudobulbus Cremastrae seu Pleiones extracts in preparing overriding resistance Acinetobacter bauamnnii drug
Using.
To achieve the goals above, the present invention is achieved by the following technical programs:
Inventor establishes drug resistance Acinetobacter bauamnnii-Caenorhabditis elegans infection model, is extracted using it to edible tulip
The activity in vivo of the overriding resistance Acinetobacter bauamnnii of object is detected, as the result is shown its can significantly improve Caenorhabditis elegans at
Motility rate illustrates that it has good biological control effect to overriding resistance Acinetobacter bauamnnii, is conducive to edible tulip and solves superbacteria
Have accumulated good theoretical basis and practical experience.
Therefore claimed edible tulip in anti-Acinetobacter bauamnnii or is prepared in anti-Acinetobacter bauamnnii drug
Using.
The present invention is also claimed Pseudobulbus Cremastrae seu Pleiones extract in anti-Acinetobacter bauamnnii or prepares anti-Acinetobacter bauamnnii drug
In application.
Wherein, the Acinetobacter bauamnnii is drug resistance Acinetobacter bauamnnii.
The anti-Acinetobacter bauamnnii drug is the drug of internal anti-Acinetobacter bauamnnii.
The drug resistance refers to penicillins, cephalosporins, Carbapenems, beta-lactam class antibiotic/beta-lactam
Compound formulation, fluoroquinolones and/or the aminoglycoside medicaments of enzyme inhibitor have drug resistance.
Furthermore it is preferred that the Pseudobulbus Cremastrae seu Pleiones extract is the water extract of edible tulip.
It is highly preferred that the preparation method of the water extract of the edible tulip the following steps are included:
S1. edible tulip is mixed with water according to mass ratio 1:5~20,90~100 DEG C of 1~2h of heating and refluxing extraction, solid-liquid
Separation；
S2. the obtained solid of step S1 is mixed with water according to mass ratio 1:5~20,90~100 DEG C of heating and refluxing extractions 1
~2h is separated by solid-liquid separation；
S3. merge the liquid that step S1 is obtained and the liquid that step S2 is obtained, removal solvent obtains drug extract.
It is highly preferred that the mass ratio of edible tulip and water is 1:12 in step S1.
It is highly preferred that extraction conditions are 100 DEG C of extraction 1.5h in step S1 and S2.
It is highly preferred that the mass ratio of solid and water is 1:8 in step S2.
Compared with prior art, the invention has the following beneficial effects:
The invention discloses Pseudobulbus Cremastrae seu Pleiones extracts to prepare the application in overriding resistance Acinetobacter bauamnnii drug.Benefit of the invention
The nematode for having infected drug resistance Acinetobacter bauamnnii is treated with the extract of edible tulip, shows the extract of edible tulip to resistance to
Medicine Acinetobacter bauamnnii has good bactericidal effect, this is provided well to research and develop novel overriding resistance Acinetobacter bauamnnii drug
Early-stage study basis, for solve clinically drug resistance Acinetobacter bauamnnii infection bring dawn without the available predicament of medicine.It utilizes
The extract of edible tulip is prevented and treated drug resistance Acinetobacter bauamnnii, and method is quick, cheap, and it is convenient to operate.
Specific embodiment
The present invention is made below with reference to specification and specific embodiment and further being elaborated, the embodiment is only used
In explaining the present invention, it is not intended to limit the scope of the present invention.Test method as used in the following examples is such as without special theory
It is bright, it is conventional method；Used material, reagent etc., unless otherwise specified, for the reagent and material commercially obtained
Material.
The preparation of 1 Pseudobulbus Cremastrae seu Pleiones extract of embodiment and its detection of bacteriostatic activity
One, experimental method
1, the preparation of Pseudobulbus Cremastrae seu Pleiones extract
Three parts of edible tulips are weighed, every part of 2g is respectively placed in 3 100mL round-bottomed flasks, by the material ratio of 1:12, respectively
The different solvent 24mL of water, 50% ethyl alcohol, three kinds of 95% ethyl alcohol is added；The flask of three different extracting solutions is respectively set different
Extracting temperature is 100 DEG C, 90 DEG C, 85 DEG C, by medical filtration after heating and refluxing extraction 1.5h；Distinguish again by the material ratio of 1:8
Corresponding extracting solution is added, 100 DEG C, 90 DEG C, 85 DEG C of extraction 1.5h, filter and merge whole medical fluids, be evaporated off under reduced pressure whole respectively
Solvent obtains drug extract, is weighed and placed in 1.5mL centrifuge tube, places in -20 DEG C of refrigerators stand-by.It is kind that three kinds of mountains are prepared
Mushroom extract (water extract of edible tulip, 50% ethanol extract of edible tulip, edible tulip 95% ethanol extract).
2, drug resistance Acinetobacter bauamnnii-Caenorhabditis elegans infection model
It is using 20% brain heart infusion (BHI) fluid nutrient medium containing 10 μm of ol iron ions that synchronized nematode is raw from nematode
It rinsing on long culture medium into 15mL centrifuge tube, 800rpm revolving speed is centrifuged 1min, discards supernatant liquid, and add culture medium to 2mL or so,
Being placed in temperature is 25 DEG C, spare in the insulating box that humidity is 85%；20%BHI is poured into 3mL opacity tube, from Luria-
It is sufficiently mixed in opacity tube with sterile swab stick picking drug resistance Acinetobacter bauamnnii single bacterium colony on Bertan (LB) agar plate
It is even, bacteria concentration is adjusted to 0.5 maxwell unit (about 1 × 10 using than turbid instrument8CFU/mL 250 μ L), then with liquid-transfering gun are sucked out extremely
In new 5mL centrifuge tube, 2250 μ L of 20%BHI fluid nutrient medium is added, bacterium solution is diluted 10 times to 1 × 107CFU/mL；With
The bacterium solution that the liquid-transfering gun of 1000 μ L draws after 2mL dilution is added in nematode pipe, makes final concentration of the 5 of drug resistance Acinetobacter bauamnnii
×106CFU/mL, being put into temperature later is 25 DEG C, is cultivated in the constant temperature and humidity incubator that humidity is 85%；It is incubated for infection 6h altogether
Afterwards, it is cleaned at least 3 times with M9 fluid nutrient medium, 180 μ L of draw solution is assigned in 96 orifice plates, and 15~20, every hole is advisable.System
It is standby to obtain drug resistance Acinetobacter bauamnnii-Caenorhabditis elegans infection model.
3, Pseudobulbus Cremastrae seu Pleiones extract antibacterial activity in vivo detects
The drug resistance Acinetobacter bauamnnii being prepared using previous step-Caenorhabditis elegans infection model is carried out edible tulip and mentioned
Object antibacterial activity in vivo is taken to detect.
Using the polymyxin B of 20 μ g/mL as positive controls, using 10% DMSO as negative control group, with difference
Edible tulip (water, 50% ethyl alcohol, 95% second of concentration (10000 μ g/mL, 1000 μ g/mL, 100 μ g/mL, 10 μ g/mL, 1 μ g/mL)
Alcohol) for extract as experimental group, every group sets 3 groups of parallel controls.
The Pseudobulbus Cremastrae seu Pleiones extract preparation method of various concentration: weighing the extract of 10mg into 1.5mL centrifuge tube, is added
The DMSO of 100 μ L, the BHI culture medium for adding 900 μ L are sufficiently mixed dissolution extract, and 100 μ L are then successively sucked out and are added
900 μ L BHI culture mediums are serially diluted 5 times, and respectively 10000 μ g/mL, 1000 μ g/mL, 100 μ g/mL, 10 μ g/mL, 1 μ are obtained
The extracting solution of g/mL.
20 μ L Pseudobulbus Cremastrae seu Pleiones extracts are separately added into corresponding aperture, make Pseudobulbus Cremastrae seu Pleiones extract with 1000 μ g/mL, 100 μ g/
ML, 10 μ g/mL, 1 μ g/mL, 0.1 μ g/mL gradient final concentration extract intervened；After being incubated for 36h in 25 DEG C of insulating box,
Therapeutic effect of the Chinese medical extract to infection nematode of various concentration is judged by the survival rate of nematode.With negative control and the positive
Control is as control.
Two, experimental result is shown in Table 1.
Table 1:
The results show that Pseudobulbus Cremastrae seu Pleiones extract, including water extract and alcohol extract, there is obvious overriding resistance Bao Man in vivo not
The effect of lever bacterium, wherein the water extract of edible tulip has the effect of better biological control nematode relative to ethanol extract,
The survival rate of infection nematode can reach 20% or more.
The preparation of 1 forsythia suspense extraction of reference examples and its detection of bacteriostatic activity
One, experimental method
The preferable forsythia suspense extraction of external overriding resistance Acinetobacter bauamnnii activity being had verified that with this field is control,
The preparation and its detection of bacteriostatic activity in vivo of forsythia suspense extraction are carried out according to 1 method of embodiment.
Two, experimental result is shown in Table 2.
Table 2:
The results show that forsythia suspense extraction influences very little to the survival rate of infection nematode, without internal overriding resistance Bao Man not lever
The effect of bacterium.
Claims (10)
1. edible tulip is in anti-Acinetobacter bauamnnii or prepares application in anti-Acinetobacter bauamnnii drug.
2. Pseudobulbus Cremastrae seu Pleiones extract is in anti-Acinetobacter bauamnnii or prepares application in anti-Acinetobacter bauamnnii drug.
3. application according to claim 1 or claim 2, which is characterized in that the anti-Acinetobacter bauamnnii drug is internal anti-Bao Man
The drug of acinetobacter calcoaceticus.
4. application according to claim 1 or claim 2, which is characterized in that the Acinetobacter bauamnnii is drug resistance Acinetobacter bauamnnii.
5. applying according to claim 4, which is characterized in that the drug resistance refers to green to penicillins, cephalosporins, carbon
Mould alkenes, beta-lactam class antibiotic/beta lactamase restrainer compound formulation, fluoroquinolones and/or aminoglycoside medicine
Object has drug resistance.
6. applying according to claim 2, which is characterized in that the Pseudobulbus Cremastrae seu Pleiones extract is the water extract of edible tulip.
7. applying according to claim 6, which is characterized in that the preparation method of the Pseudobulbus Cremastrae seu Pleiones extract includes following step
It is rapid:
S1. edible tulip is mixed according to mass ratio 1:5~20,90~100 DEG C of 1~2h of heating and refluxing extraction with water, is separated by solid-liquid separation；
S2. the obtained solid of step S1 is mixed with water according to mass ratio 1:5~20,90~100 DEG C of heating and refluxing extractions 1~
2h is separated by solid-liquid separation；
S3. merge the liquid that step S1 is obtained and the liquid that step S2 is obtained, removal solvent obtains drug extract.
8. applying according to claim 7, which is characterized in that in step S1, the mass ratio of edible tulip and water is 1:12.
9. applying according to claim 7, which is characterized in that extraction conditions are 100 DEG C of extraction 1.5h in step S1 and S2.
10. applying according to claim 7, which is characterized in that in step S2, the mass ratio of solid and water is 1:8.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201910493104.3A CN110302308B (en) | 2019-06-06 | 2019-06-06 | Application of Indian iphigenia bulb extract in preparation of drug-resistant acinetobacter baumannii drug |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201910493104.3A CN110302308B (en) | 2019-06-06 | 2019-06-06 | Application of Indian iphigenia bulb extract in preparation of drug-resistant acinetobacter baumannii drug |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN110302308A true CN110302308A (en) | 2019-10-08 |
| CN110302308B CN110302308B (en) | 2023-10-03 |
Family
ID=68075138
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201910493104.3A Active CN110302308B (en) | 2019-06-06 | 2019-06-06 | Application of Indian iphigenia bulb extract in preparation of drug-resistant acinetobacter baumannii drug |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN110302308B (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN112546153A (en) * | 2020-12-11 | 2021-03-26 | 中国人民解放军南部战区总医院 | Acinetobacter baumannii-resistant composition and preparation method and application thereof |
Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104383047A (en) * | 2012-12-17 | 2015-03-04 | 神威药业集团有限公司 | Applications of Cape Jasmine extract in preparation of anti-Acinetobacter baumannii drug |
| CN105770008A (en) * | 2016-03-04 | 2016-07-20 | 沈阳药科大学 | New application of folium syringae extract in preparing drugs for resisting drug-resistant bacterium infection diseases |
| CN105816511A (en) * | 2016-05-10 | 2016-08-03 | 中山大学 | Application of pithecellobium clypearia extracts to preparation of multi-drug resistant acinetobacter baumannii medicine |
| CN106562943A (en) * | 2016-11-09 | 2017-04-19 | 济南市儿童医院 | Memantine and application thereof in preparation of medicines for therapy of acinetobacter baumannii infection |
| CN107751089A (en) * | 2017-08-29 | 2018-03-06 | 广州军区广州总医院 | It is a kind of that the method for resisting general resistance Acinetobacter bauamnnii medicine is screened using Caenorhabditis elegans |
| CN108719204A (en) * | 2017-07-14 | 2018-11-02 | 上海交通大学医学院附属新华医院 | A kind of drug resistance Acinetobacter bauamnnii infects method for building up and its application of Caenorhabditis elegans medicaments sifting model |
-
2019
- 2019-06-06 CN CN201910493104.3A patent/CN110302308B/en active Active
Patent Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104383047A (en) * | 2012-12-17 | 2015-03-04 | 神威药业集团有限公司 | Applications of Cape Jasmine extract in preparation of anti-Acinetobacter baumannii drug |
| CN105770008A (en) * | 2016-03-04 | 2016-07-20 | 沈阳药科大学 | New application of folium syringae extract in preparing drugs for resisting drug-resistant bacterium infection diseases |
| CN105816511A (en) * | 2016-05-10 | 2016-08-03 | 中山大学 | Application of pithecellobium clypearia extracts to preparation of multi-drug resistant acinetobacter baumannii medicine |
| CN106562943A (en) * | 2016-11-09 | 2017-04-19 | 济南市儿童医院 | Memantine and application thereof in preparation of medicines for therapy of acinetobacter baumannii infection |
| CN108719204A (en) * | 2017-07-14 | 2018-11-02 | 上海交通大学医学院附属新华医院 | A kind of drug resistance Acinetobacter bauamnnii infects method for building up and its application of Caenorhabditis elegans medicaments sifting model |
| CN107751089A (en) * | 2017-08-29 | 2018-03-06 | 广州军区广州总医院 | It is a kind of that the method for resisting general resistance Acinetobacter bauamnnii medicine is screened using Caenorhabditis elegans |
Non-Patent Citations (4)
| Title |
|---|
| 段欣冉: "中药抑制鲍曼不动杆菌的研究进展", 《中国感染控制杂志》 * |
| 段欣冉: "中药抑制鲍曼不动杆菌的研究进展", 《中国感染控制杂志》, vol. 16, no. 6, 1 June 2017 (2017-06-01), pages 577 - 581 * |
| 段欣冉: "高通量筛选平台用于清热解毒中药的体内抗菌活性研究", 《中国优秀硕士学位论文全文数据库医药卫生科技辑》 * |
| 段欣冉: "高通量筛选平台用于清热解毒中药的体内抗菌活性研究", 《中国优秀硕士学位论文全文数据库医药卫生科技辑》, no. 1, 15 January 2019 (2019-01-15), pages 1 * |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN112546153A (en) * | 2020-12-11 | 2021-03-26 | 中国人民解放军南部战区总医院 | Acinetobacter baumannii-resistant composition and preparation method and application thereof |
Also Published As
| Publication number | Publication date |
|---|---|
| CN110302308B (en) | 2023-10-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101953784B (en) | Veterinary suspension containing amoxicillin, colistin sulfate and prednisolone and preparation method thereof | |
| Uddin et al. | Antibacterial activity of the ethanol extracts of Hibiscus rosa-sinensis leaves and flowers against clinical isolates of bacteria | |
| CN110302282A (en) | Herba Patriniae extract is preparing the application in overriding resistance Acinetobacter bauamnnii drug | |
| CN108719204A (en) | A kind of drug resistance Acinetobacter bauamnnii infects method for building up and its application of Caenorhabditis elegans medicaments sifting model | |
| CN110251558A (en) | A kind of radix scutellariae dregs of a decoction semisolid fermentation technical method and its application | |
| CN105770008B (en) | New application of clove leaf extract in preparation of drug-resistant bacteria infection disease resistant drugs | |
| CN107751089A (en) | It is a kind of that the method for resisting general resistance Acinetobacter bauamnnii medicine is screened using Caenorhabditis elegans | |
| CN110302308A (en) | Pseudobulbus Cremastrae seu Pleiones extract is preparing the application in overriding resistance Acinetobacter bauamnnii drug | |
| CN104651473B (en) | The method for determining the sub-lethal dose staphylococcus aureus resistance to the action of a drug and drug resistance simultaneously | |
| CN105456306B (en) | Rattan lycopod extract is preparing the application in antibacterial anti-inflammatory natural drug | |
| CN113908166B (en) | Use of N-acetylneuraminic acid for preparing promoter for promoting Roseburia proliferation | |
| CN110269885A (en) | Radix Tinosporae extract is preparing the application in overriding resistance Acinetobacter bauamnnii drug | |
| CN110269923A (en) | Turmeric P.E is preparing the application in overriding resistance Acinetobacter bauamnnii drug | |
| CN110302219A (en) | Cortex Pseudolaricis extract is preparing the application in overriding resistance Acinetobacter bauamnnii drug | |
| CN112245566B (en) | New use of Scutellariae radix flavonoid and/or metal ion complexing agent in synergistic polymyxin antibiotic antibacterial effect | |
| CN115838661A (en) | Lactobacillus plantarum magpie gentlemen 18, lactobacillus plantarum preparation and application thereof | |
| CN101612204A (en) | Medicament-resistant inhibitor for porcine streptococcus | |
| CN103432214B (en) | Preparation method and application of effective components of polygonum capitatum | |
| CN105079289B (en) | Fermented Chinese gall herb and tea leaves are preparing the application in Anti-helicobacter pylori drugs | |
| CN108888685B (en) | Application of Tetrastigma hemsleyanum Diels et Gilg extract TH-w part to staphylococcus aureus and action method thereof | |
| CN110464802A (en) | Compound dendrobium officinale mouth sprays and preparation method thereof | |
| CN105476984B (en) | Purposes of the Oridonin or derivatives thereof in preparation treatment antibiotic sensitizer | |
| CN103083448A (en) | Rhubarb and phellodendron medicinal pair extract for synergistically improving tinea pedis resistance | |
| CN112546153A (en) | Acinetobacter baumannii-resistant composition and preparation method and application thereof | |
| CN108653342A (en) | A kind of microbial antibacterial extract and its preparation method and application |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| GR01 | Patent grant | ||
| GR01 | Patent grant |